Table: Taiko Pharmaceutical - 6-MTH group results

Taiko Pharmaceutical

12/11/2020 06:00

Nov 12 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended      9 months to 
                  Sep 30, 2020        Sep 30, 2019       Dec 31, 2020  
                     LATEST             YEAR-AGO            LATEST     
                     RESULTS             RESULTS           FORECAST    
  Sales               10.97               4.39              18.00      
                                       (+14.6 pct)                     
  Operating            4.24              980 mln             5.50      
                                       (+52.3 pct)                     
  Recurring            4.11              882 mln             5.30      
                                       (+46.2 pct)                     
  Net                  2.86              641 mln             3.80      
                                       (+43.2 pct)                     
  EPS               66.29 yen           15.06 yen         88.49 yen    
  EPS Diluted       65.95 yen           15.05 yen                      
  Ann Div                               50.00 yen         17.00 yen    
  -Q2 div           7.00 yen            10.00 yen                      
  -Q4 div                               40.00 yen         10.00 yen    
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T